Letters in Applied NanoBioScience was established in 2012, with its first issue published on 30 March 2012.
Since its establishment, the journal has provided an international peer-reviewed publication venue for research at the interface of nanoscience, biosciences, applied chemistry, materials science, biotechnology, and related interdisciplinary fields, with particular emphasis on the development and application of nanoscale systems in biological, biomedical, environmental, and technological contexts.
In 2014, publishing responsibility for Letters in Applied NanoBioScience was transferred to AMG Transcend Association, which has since been responsible for the journal’s publication, publishing infrastructure, and publisher-level governance. Scientific evaluation, peer review, and manuscript-level editorial decisions remain under the authority of the journal’s editorial structure and are conducted in accordance with the journal’s policies on editorial independence, peer review, publication ethics, and research integrity.
The journal has maintained continuous electronic publication under ISSN 2284-6808 and currently follows a quarterly publication schedule of four issues per year.
Its editorial policies and publishing procedures have been developed over time to support transparency, scientific rigor, research integrity, and responsible scholarly communication while preserving the journal’s interdisciplinary profile in applied nanobioscience.
Current information concerning bibliographic coverage is provided on the journal’s Indexing and Abstracting page, while citation-based indicators are reported separately under Journal Metrics.
The journal has been indexed in Scopus since 2019.
Information concerning the publisher’s history, governance, and publishing responsibilities is available through AMG Transcend Association.